Emerald Bioventures, LLC

2 filings 1 distinct issuers Active 2026-04-27 → 2026-05-29

1 STRATEGIC

Track Record

Total filings

1 SCHEDULE 13D/A · 1 SCHEDULE 13D

Distinct issuers

50% issuer diversity

Median stake

28.35%

50,623,069 avg shares

AI briefs cached

1/2

intent-classified filings

Backtested Performance · post-filing returns (split + dividend adjusted)

Median 30d

+65.5%

across 2 filings · win rate 50%

Median 60d

+8214.8%

across 2 filings · win rate 100%

Median 90d

+42875.6%

across 1 filings · win rate 100%

Median 1y

—

across 0 filings · win rate —

Anchor: closest trading day on/after filing's date_of_event. Source: Yahoo Finance daily adj_close. Past performance is not indicative of future results.

Filings · 2 total

Filed	Form	Issuer	Stake	Shares	Intent
2026-05-29	SCHEDULE 13D/A	Galera Therapeutics, Inc.GRTX	30.20%	61,029,978		view →
2026-04-27	SCHEDULE 13D	Galera Therapeutics, Inc.GRTX	26.50%	40,216,160	STRATEGIC	view →

Alert me when Emerald Bioventures, LLC files anything

Free. We email you when criteria match. One-click unsubscribe in every email.

Track this filer's every move in real time.

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →